Display options
Share it on

Front Physiol. 2014 Aug 14;5:295. doi: 10.3389/fphys.2014.00295. eCollection 2014.

Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction.

Frontiers in physiology

Maike Knorr, Thomas Münzel, Philip Wenzel

Affiliations

  1. Department of Medicine 2 and Center for Thrombosis and Hemostasis University Medical Center Mainz, Mainz, Germany.

PMID: 25177297 PMCID: PMC4132269 DOI: 10.3389/fphys.2014.00295

Abstract

Inflammatory monocytes and macrophages have been identified as key players in the pathogenesis of atherosclerosis, arterial hypertension, and myocardial infarction (MI). They become powerful mediators of vascular inflammation through their capacity to secrete and induce the production of proinflammatory cytokines, chemokines and adhesion molecules and through the production of reactive oxygen species mainly via their NADPH oxidase. Importantly, a crosstalk exists between NK cells and monocytes that works via a feedforwad amplification loop of T-bet/Interferon-gamma/interleukin-12 signaling, that causes mutual activation of both NK cells and monocytes and that fosters recruitment of inflammatory cells to sites of inflammation. Recently, we have discovered that this crosstalk is crucial for the unrestricted development of angiotensin II (ATII) induced vascular injury in arterial hypertension, the most important risk factor for atherosclerosis and cardiovascular disease worldwide. In this review, we will also discuss possible implications of this interplay between NK cells and monocytes for the pathogenesis of coronary atherosclerosis and myocardial infarction and potential therapeutic options.

Keywords: atherosclerosis; monocytes; myocardial infarction; nk cells; vascular inflammation

References

  1. Circulation. 2011 Sep 20;124(12):1370-81 - PubMed
  2. Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1506-16 - PubMed
  3. Circulation. 1989 Dec;80(6):1816-27 - PubMed
  4. Am J Physiol Heart Circ Physiol. 2010 Apr;298(4):H1273-82 - PubMed
  5. Nat Rev Immunol. 2011 Oct 14;11(11):723-37 - PubMed
  6. PLoS One. 2012;7(3):e32691 - PubMed
  7. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21659-64 - PubMed
  8. Lab Invest. 1988 Aug;59(2):200-13 - PubMed
  9. PLoS One. 2010 Jan 25;5(1):e8852 - PubMed
  10. Annu Rev Immunol. 2004;22:405-29 - PubMed
  11. J Mol Cell Cardiol. 1998 Dec;30(12):2567-76 - PubMed
  12. Nat Immunol. 2006 Dec;7(12):1334-42 - PubMed
  13. Circulation. 2008 May 20;117(20):2645-56 - PubMed
  14. Atherosclerosis. 2008 Jul;199(1):65-72 - PubMed
  15. Circulation. 1983 May;67(5):1016-23 - PubMed
  16. Front Immunol. 2013 Jan 04;3:403 - PubMed
  17. Blood. 1982 Jun;59(6):1317-29 - PubMed
  18. Front Biosci. 2006 May 01;11:1569-76 - PubMed
  19. EMBO J. 2004 Jan 28;23(2):255-9 - PubMed
  20. J Immunol. 2001 Jun 15;166(12):7353-61 - PubMed
  21. Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1049-54 - PubMed
  22. Atherosclerosis. 2005 Jun;180(2):423-7 - PubMed
  23. J Mol Cell Cardiol. 2013 Nov;64:51-8 - PubMed
  24. J Immunol. 2002 Apr 1;168(7):3536-42 - PubMed
  25. FASEB J. 2008 Oct;22(10):3595-606 - PubMed
  26. J Exp Med. 2007 Nov 26;204(12):3037-47 - PubMed
  27. Immunity. 2012 Jun 29;36(6):1047-59 - PubMed
  28. Thromb Haemost. 2009 Apr;101(4):626-34 - PubMed
  29. Am J Cardiol. 2000 Jun 1;85(11):1288-91 - PubMed
  30. Immunity. 2003 Jul;19(1):71-82 - PubMed
  31. Circulation. 2011 Feb 1;123(4):400-8 - PubMed
  32. Blood. 2011 Apr 28;117(17):4511-8 - PubMed
  33. Am J Pathol. 2010 Oct;177(4):1576-91 - PubMed
  34. Cardiovasc Res. 2001 Feb 1;49(2):399-407 - PubMed
  35. Nature. 1996 Oct 31;383(6603):787-93 - PubMed
  36. Heart Vessels. 2011 Nov;26(6):637-45 - PubMed
  37. Blood. 2007 May 1;109(9):3776-85 - PubMed
  38. Immun Ageing. 2007 May 08;4:3 - PubMed
  39. Cardiovasc Res. 2014 Apr 1;102(1):128-37 - PubMed
  40. J Immunol. 2008 Nov 15;181(10):6711-9 - PubMed
  41. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3725-9 - PubMed
  42. Blood. 2008 Aug 15;112(4):1461-71 - PubMed
  43. J Am Coll Cardiol. 2010 Apr 13;55(15):1629-38 - PubMed
  44. Clin Diagn Lab Immunol. 2005 Sep;12(9):1041-9 - PubMed
  45. J Leukoc Biol. 2004 Feb;75(2):163-89 - PubMed
  46. Nature. 2012 Jul 19;487(7407):325-9 - PubMed
  47. Hypertension. 2008 Apr;51(4):905-14 - PubMed
  48. J Clin Invest. 1989 Dec;84(6):2017-20 - PubMed
  49. J Exp Med. 1992 Nov 1;176(5):1387-98 - PubMed
  50. J Am Coll Cardiol. 2009 Jul 7;54(2):130-8 - PubMed
  51. Annu Rev Immunol. 1997;15:749-95 - PubMed
  52. J Exp Med. 1968 Nov 1;128(5):1201-21 - PubMed
  53. Circ Res. 2013 Mar 1;112(5):792-801 - PubMed
  54. Cardiovasc Res. 2009 Feb 15;81(3):474-81 - PubMed
  55. J Lipid Res. 2009 Apr;50 Suppl:S277-81 - PubMed
  56. J Clin Invest. 2007 Jan;117(1):185-94 - PubMed
  57. FASEB J. 2013 Mar;27(3):871-81 - PubMed
  58. Atherosclerosis. 2005 Dec;183(2):316-21 - PubMed
  59. J Exp Med. 1997 Aug 29;186(5):739-47 - PubMed
  60. Scand J Immunol. 2008 Feb;67(2):152-9 - PubMed
  61. Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1313-9 - PubMed
  62. J Craniomaxillofac Surg. 2012 Dec;40(8):e432-7 - PubMed
  63. Nature. 2013 Apr 25;496(7446):445-55 - PubMed
  64. Science. 2009 Jul 31;325(5940):612-6 - PubMed
  65. Scand J Immunol. 2005 Oct;62(4):334-41 - PubMed
  66. J Leukoc Biol. 2000 May;67(5):699-704 - PubMed
  67. Nat Immunol. 2008 May;9(5):503-10 - PubMed
  68. Pediatr Blood Cancer. 2007 Oct 15;49(5):615-23 - PubMed
  69. J Immunol. 2004 Feb 15;172(4):2001-5 - PubMed

Publication Types